These benefits, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 guidance the notion of focusing on ACKR3 as a novel strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-connected Diseases. These outcomes advise that https://mickk878anu8.topbloghub.com/profile